Question to the Department of Health and Social Care:

To ask His Majesty's Government what plans they have (1) to deliver their clinical research vision, and (2) to provide funding to support the growth of the UK’s phase 1 trial capacity.

The Future of UK Clinical Research Delivery 2022-2025 implementation plan summarises the progress made in 2021-22 towards delivering the vision and the actions that are being taken by the various delivery partners (the National Institute for Health and Care Research (NIHR), NHS England, the Medicines and Healthcare products Regulatory Agency, Health Research Authority and Devolved Administrations) between 2022 and 2025 to make progress to achieve our vision in full by 2031. This plan is being delivered under the UK Recovery, Resilience and Growth Programme.

To support the growth of phase 1 trial capacity the NIHR has confirmed an investment of £969 million over the next five years in its early translational research infrastructure, which includes the NIHR Biomedical Research Centres, NIHR Clinical Research Facilities and NIHR/Cancer Research UK Experimental Cancer Medicine Centres.